enow.com Web Search

  1. Ads

    related to: new cholesterol drug

Search results

  1. Results from the WOW.Com Content Network
  2. What's the latest on cholesterol, heart health, GLP-1 drugs ...

    www.aol.com/whats-latest-cholesterol-heart...

    This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.

  3. FDA approves drug that lowers cholesterol in a new way

    www.aol.com/news/fda-approves-drug-lowers...

    U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like ...

  4. In two studies, experimental drugs for cholesterol show ...

    www.aol.com/news/two-studies-experimental-drugs...

    New, experimental drugs designed to drive down dangerous levels of cholesterol were shown to be safe and effective in two groundbreaking bodies of research presented Sunday at an annual meeting of ...

  5. Alirocumab - Wikipedia

    en.wikipedia.org/wiki/Alirocumab

    At the same time, pharmacy benefit managers such as Express Scripts and CVS Caremark, while recognizing that the new drugs could help patients who were otherwise left with uncontrolled cholesterol levels, and recognizing that injectable biopharmaceuticals will always be more expensive than pills, and especially more expensive than generic pills ...

  6. Bempedoic acid - Wikipedia

    en.wikipedia.org/wiki/Bempedoic_acid

    Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels). [2] [3]The most common side effects include hyperuricemia (high blood levels of uric acid), pain in arms or legs, and anemia (low red blood cell counts).

  7. Obicetrapib - Wikipedia

    en.wikipedia.org/wiki/Obicetrapib

    Obicetrapib is an experimental CETP inhibitor that is intended to treat dyslipidemia.In a clinical trial, as an add-on to statins, compared with placebo, it decreased concentrations of LDL-C (by up to 51%), apolipoprotein B (by up to 30%) and non-high-density lipoprotein cholesterol (non-HDL-C) (by up to 44%), and increased HDL-C concentration (by up to 165%).

  1. Ads

    related to: new cholesterol drug